Progressive supranuclear palsy: current approach and challenges to diagnosis and treatment

Although much improved, clinical PSP criteria alone remain insufficient and emphasize the need for improved biomarkers to identify patients at early stages to direct appropriate therapeutic strategies and target potential research.